Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.

Groveman BR, Orrù CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B.

Acta Neuropathol Commun. 2018 Feb 9;6(1):7. doi: 10.1186/s40478-018-0508-2.

2.

Ex-vivo quantitative susceptibility mapping of human brain hemispheres.

Evia AM, Kotrotsou A, Tamhane AA, Dawe RJ, Kapasi A, Leurgans SE, Schneider JA, Bennett DA, Arfanakis K.

PLoS One. 2017 Dec 20;12(12):e0188395. doi: 10.1371/journal.pone.0188395. eCollection 2017.

3.

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM.

Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8. Review.

PMID:
29117955
4.

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.

Rabinovici GD, Carrillo MC, Forman M, DeSanti S, Miller DS, Kozauer N, Petersen RC, Randolph C, Knopman DS, Smith EE, Isaac M, Mattsson N, Bain LJ, Hendrix JA, Sims JR.

Alzheimers Dement (N Y). 2016 Sep 20;3(1):83-91. doi: 10.1016/j.trci.2016.09.002. eCollection 2017 Jan. Review.

5.

Blood Pressure's Role in Alzheimer Disease Pathology.

Hughes TM, Lockhart SN, Smagula SF.

Am J Geriatr Psychiatry. 2018 Jan;26(1):23-24. doi: 10.1016/j.jagp.2017.09.019. Epub 2017 Sep 25. No abstract available.

PMID:
29050913
6.

'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials.

Leoutsakos JM, Gross AL, Jones RN, Albert MS, Breitner JCS.

J Prev Alzheimers Dis. 2016;3(4):229-235. doi: 10.14283/jpad.2016.120.

7.

Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study.

Bangen KJ, Preis SR, Delano-Wood L, Wolf PA, Libon DJ, Bondi MW, Au R, DeCarli C, Brickman AM.

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):50-56. doi: 10.1097/WAD.0000000000000215.

PMID:
28984639
8.

Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.

Bressler J, Yu B, Mosley TH, Knopman DS, Gottesman RF, Alonso A, Sharrett AR, Wruck LM, Boerwinkle E.

Transl Psychiatry. 2017 Jul 18;7(7):e1173. doi: 10.1038/tp.2017.118.

9.

Divergent Roles of Vascular Burden and Neurodegeneration in the Cognitive Decline of Geriatric Depression Patients and Mild Cognitive Impairment Patients.

Ye Q, Su F, Gong L, Shu H, Liao W, Xie C, Zhou H, Zhang Z, Bai F.

Front Aging Neurosci. 2017 Sep 1;9:288. doi: 10.3389/fnagi.2017.00288. eCollection 2017.

10.

Ultra-rare mutations in SRCAP segregate in Caribbean Hispanic families with Alzheimer disease.

Vardarajan BN, Tosto G, Lefort R, Yu L, Bennett DA, De Jager PL, Barral S, Reyes-Dumeyer D, Nagy PL, Lee JH, Cheng R, Medrano M, Lantigua R, Rogaeva E, St George-Hyslop P, Mayeux R.

Neurol Genet. 2017 Aug 24;3(5):e178. doi: 10.1212/NXG.0000000000000178. eCollection 2017 Oct.

11.

The borderland between normal aging and dementia.

Lo RY.

Ci Ji Yi Xue Za Zhi. 2017 Apr-Jun;29(2):65-71. doi: 10.4103/tcmj.tcmj_18_17. Review.

12.

Statistically Derived Subtypes and Associations with Cerebrospinal Fluid and Genetic Biomarkers in Mild Cognitive Impairment: A Latent Profile Analysis.

Eppig JS, Edmonds EC, Campbell L, Sanderson-Cimino M, Delano-Wood L, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2017 Aug;23(7):564-576. doi: 10.1017/S135561771700039X. Epub 2017 Jun 5.

13.

Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.

Morris JK, Uy RAZ, Vidoni ED, Wilkins HM, Archer AE, Thyfault JP, Miles JM, Burns JM.

J Alzheimers Dis. 2017;58(4):1129-1135. doi: 10.3233/JAD-170148.

14.

How Does Psychosocial Behavior Contribute to Cognitive Health in Old Age?

Wilson RS, Bennett DA.

Brain Sci. 2017 May 23;7(6). pii: E56. doi: 10.3390/brainsci7060056.

15.

Impact of multiple pathologies on the threshold for clinically overt dementia.

Kapasi A, DeCarli C, Schneider JA.

Acta Neuropathol. 2017 Aug;134(2):171-186. doi: 10.1007/s00401-017-1717-7. Epub 2017 May 9. Review.

PMID:
28488154
16.

Applying fluid biomarkers to Alzheimer's disease.

Zetterberg H.

Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C3-C10. doi: 10.1152/ajpcell.00007.2017. Epub 2017 Apr 19. Review.

PMID:
28424166
17.

Peripapillary Retinal Nerve Fiber Layer Thickness and the Evolution of Cognitive Performance in an Elderly Population.

Méndez-Gómez JL, Rougier MB, Tellouck L, Korobelnik JF, Schweitzer C, Delyfer MN, Amieva H, Dartigues JF, Delcourt C, Helmer C.

Front Neurol. 2017 Mar 21;8:93. doi: 10.3389/fneur.2017.00093. eCollection 2017.

18.

Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer's Disease.

Hess NC, Smart NA.

Front Aging Neurosci. 2017 Mar 3;9:48. doi: 10.3389/fnagi.2017.00048. eCollection 2017. Review.

19.

Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery.

Bennett DA.

PLoS Med. 2017 Mar 14;14(3):e1002256. doi: 10.1371/journal.pmed.1002256. eCollection 2017 Mar.

20.

Author response: Incident parkinsonism in older adults without Parkinson disease.

Buchman AS, Bennett DA.

Neurology. 2017 Feb 28;88(9):920. doi: 10.1212/WNL.0000000000003674. No abstract available.

Supplemental Content

Support Center